posted
Just beginning it's U.S. rollout. A topical pain reliever that's all natural.
With a baby boomer crowd getting older, this could be huge!
It had a big reception at an AARP convention in Nov-04. It will be featured at the Bob Hope Desert Classic this month that probably gets 50,000 spectators.
Posts: 424 | From: Baltimore, MD | Registered: Apr 2004
| IP: Logged |
posted
Toronto Star Says O24 is 'IN' for 2005; Celebrex, Naproxen Out Tuesday January 4, 8:00 am ET
TAMPA, Fla., Jan. 4, 2005 (PRIMEZONE) -- Toronto Star health editor Judy Gerstel announced arthritis drugs Vioxx(r), Celebrex(r) and naproxen are out. What's IN for 2005? Exercise, weight loss and topical pain relievers, she noted. Wrote Gerstel in her December 31st health column, ``Among the products: O24 essential oil pain reliever, from Toronto-based Swiss Medica (OTC BB:SWME.OB - News).'' Gerstel noted that topical pain relief products are ``being heavily promoted now that the high-profile drugs are losing their luster.''
Since Merck & Co's voluntary worldwide recall of its Vioxx(r) arthritis medicine, Swiss Medica's O24(tm) has become one of Canada's most popular pain relief products. Prior to the US Food & Drug Administration cautions on Celebrex(r) and naproxen, Swiss Medica began test marketing the US-patented O24(tm) at the Happy Harry's Discount Drugstore chain in Delaware. Canadian and US sales of the O24(tm) pain relief product have been robust and encouraging as Swiss Medica plans to continue its North American rollout of its flagship product during 2005.
Recently, the O24(tm) product got a boost after the FDA recommended physicians consider alternatives to Pfizer's popular arthritis medication, Celebrex(r). Noted Florida surgeon Allan N. Fields began recommending O24 as a ``selective replacement for Celebrex(r) and Bextra(r) in certain cases.'' Former surgeon to boxing legend Muhammad Ali, Dr. Fields was named ``Physician of the Year'' in early November by the AAPRP and awarded the Key to the City of Miami Beach.
In late December, Swiss Medica announced a randomized double blind clinical trial, using the O24(tm) pain relief product on patients suffering from fibromyalgia, had been completed. A final report is expected in January after the Institute of Clinical Evaluative Studies (ICES) in Toronto completes its analysis of the results.
Widely popular in Europe, the O24(tm) product has been used by Olympic athletes and former heavyweight champion Larry Holmes, recommended by the Toronto Maple Leaf's athletic trainer, medically and hospital-tested under emergency room conditions, and is currently enjoying a grassroots groundswell in both the United States and Canada because it reportedly can be used for ``pains associated with arthritis'' and not interfere with a patient's prescription medications. Also available online at http://www.024zone.com
posted
Swiss Medica Raises US$2.5 Million to Increase Size of the U.S. National Launch Thursday January 6, 8:01 am ET
TORONTO--(BUSINESS WIRE)--Jan. 6, 2005--Swiss Medica (OTCBB:SWME - News)has significantly increased the size of its initial U.S. national marketing budget for the O24(TM) Essential Oil Pain Neutralizer, through the exercise of previously issued warrants, which raised gross proceeds of US$2.5 million. "We are pleased to have minimized shareholder dilution because these warrants were issued in March 2004 and were already part of the company's existing capital structure," said Chief Executive Officer Raghu Kilambi. "These new funds substantially increase the breadth and depth of the U.S. marketing campaign to launch the O24 pain relief product in the highly competitive national pharmacy chain marketplace." ===================================== Swiss Medica To Hold Sampling Event For O24 At 46th Annual Bob Hope Chrysler Golf Classic Tuesday January 11, 9:01 am ET
TORONTO--(BUSINESS WIRE)--Jan. 11, 2005--Swiss Medica Inc. (OTC BB:SWME - News) will conduct its largest ever U.S. sampling event for the O24(TM) Essential Oil Pain Neutralizer at the 46th Annual Bob Hope Chrysler Golf Classic on January 27-30. Swiss Medica will be distributing the Company's O24 towelette samples at the PGA West's Arnold Palmer Private Golf Course in La Quinta, California to the estimated 50,000 or more attendees of this nationally televised golf tournament. O24's celebrity spokesman, former Heavyweight Boxing Champion, Larry Holmes, will attend the tournament on behalf of Swiss Medica, and also plans to visit the Coachella Valley Boxing Club, one of the organizations for which the Bob Hope Chrysler Golf Classic provides charity funding each year.
Swiss Medica will premiere its network television quality commercial teaser for the O24(TM) pain relief product at this event. The "Ask Yourself O24" thirty-second television commercial will be shown, throughout the weekend, over television monitors located in all corporate hospitality skybox suites and tents, the exclusive Bob Hope Club, the clubhouse, the Media Center, the merchandise tent, and the 18th fairway 20' high video big screen.
"We will also be offering golfing fans the O24(TM) Essential Oil Pain Neutralizer for sale at this event," President and Chief Operating Officer, Grant Johnson announced. "We learned from previous experience, at October's AARP event in Las Vegas, an overwhelming number of consumers who tested the free samples wished to also purchase our product."
Additional information about the Bob Hope Chrysler Golf Classic can be found at www.bhcc.com.
About Swiss Medica Inc.
Swiss Medica commercializes proprietary bioscience products that relieve chronic ailments. We increase our market share through focused distribution strategies in multiple sales channels. Swiss Medica's mission is to be a world leader in the commercialization of life enhancing bioscience products that improve quality of lives. Please visit our websites at www.swissmedica.com and www.O24zone.com
Swiss Medica's flagship product, the O24(TM) Essential Oil Pain Neutralizer, holds US Patent #6,444,238B1. The O24(TM) pain relief solution has been used, recommended and praised for its fast-acting and long-lasting benefits by healthcare professionals in the United States, Canada and in Europe. O24 is widely available throughout Canada in leading pharmacies and natural food stores. It is currently available in Happy Harry's Discount Drugstores in the United States, or by visiting www.O24zone.com, for ordering details and store locators.
Forward-looking statements in this news release are made pursuant to the "Safe Harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, risks relating to the ability to close transactions being contemplated, risks related to international sales and potential foreign currency exchange fluctuations, continued acceptance of Swiss Medica's products, increased levels of competition, technological changes, dependence on intellectual property rights and other risks detailed from time to time in Swiss Medica's periodic reports filed with the United States Securities and Exchange Commission and other regulatory authorities.
Swiss Medica Inc. (OTC Bulletin Board:SWME - News)
-------------------------------------------------------------------------------- Contact: Swiss Medica Inc. Investor Relations Contact: David Jones 1 866 485 4243 OR Blue Skye PR, Inc. Press Contact: Sky Wallen 813 732 6869 blueskyeinc@yahoo.com www.blueskyeinc.comPosts: 424 | From: Baltimore, MD | Registered: Apr 2004
| IP: Logged |
posted
Rite Aid Drugstore Chain To Carry Swiss Medica's O24 Pain Relief Product Tuesday January 18, 8:00 am ET
TORONTO--(BUSINESS WIRE)--Jan. 18, 2005--Swiss Medica Inc. (OTCBB:SWME - News) is pleased to announce the Rite Aid Corporation, the third largest U.S. drugstore chain by store count, will begin carrying the Company's flagship pain relief product, the O24 Essential Oil Pain Neutralizer, across its national store footprint. Swiss Medica will commence its marketing, public relations and sampling campaign in conjunction with the arrival of the Company's pain relief product on Rite Aid shelves. Swiss Medica will use its proven marketing and sampling strategies, which had been fine-tuned during the national Canadian launch of the O24 product in the fall of 2004. Multi-media advertising will be launched nationally to provide full coverage in all Rite Aid markets, especially major metropolitan areas such as New York City, Los Angeles, Philadelphia, Washington D.C., San Francisco, and Detroit. Tom Quinn, Swiss Medica's VP of U.S. Operations said, "We are proud to have Rite Aid as our newest customer and our first U.S. national drugstore chain. Rite Aid's 3,300 plus stores gives them strong presence in many of the country's largest markets and will give millions of Americans the opportunity to buy O24- the new, patented, effective and safe way to relieve their pain and resume more normal lives."
About Rite Aid Corporation
Rite Aid Corporation operates retail drugstores in the United States. During the fiscal year ended February 28, 2004 (fiscal 2003), the Company operated 3,382 stores located in 28 states across the country and in the District of Columbia. According to Chain Drug Review magazine, Rite Aid's revenues stood at $16.87 billion for FY2003.
About Swiss Medica Inc.
Swiss Medica commercializes proprietary bioscience products that relieve chronic ailments. We increase our market share through focused distribution strategies in multiple sales channels. Swiss Medica's mission is to be a world leader in the commercialization of life enhancing bioscience products that improve quality of lives. Please visit our websites at www.swissmedica.com and www.O24zone.com
Swiss Medica's flagship product, the O24(TM) Essential Oil Pain Neutralizer, holds US Patent #6,444,238B1. The O24(TM) pain relief solution has been used, recommended and praised for its fast-acting and long-lasting benefits by healthcare professionals in the United States, Canada and in Europe. O24(TM) is widely available throughout Canada in leading pharmacies and natural food stores. It is currently available in Happy Harry's Discount Drugstores in the United States, or by visiting www.O24zone.com, for ordering details and store locators.
Forward-looking statements in this news release are made pursuant to the "Safe Harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, risks relating to the ability to close transactions being contemplated, risks related to international sales and potential foreign currency exchange fluctuations, continued acceptance of Swiss Medica's products, increased levels of competition, technological changes, dependence on intellectual property rights and other risks detailed from time to time in Swiss Medica's periodic reports filed with the United States Securities and Exchange Commission and other regulatory authorities.
Swiss Medica Inc. (OTC Bulletin Board:SWME - News)
-------------------------------------------------------------------------------- Contact: Swiss Medica Inc. David Jones Investor Relations Contact 1-866-485-4243 OR Blue Skye PR, Inc. Sky Wallen Press Contact (813) 732-6869 blueskyeinc@yahoo.com www.blueskyeinc.comPosts: 424 | From: Baltimore, MD | Registered: Apr 2004
| IP: Logged |
posted
TORONTO, ONTARIO, Jan 20, 2005 (CCNMatthews via COMTEX) -- Swiss Medica Inc. (OTC BB:SWME) is pleased to announce the Company has cancelled debt agreements and redeemed debentures related to a US$1 million debt financing, which was part of the $1.5 million financing announced on December 30th, 2004. Full details are incorporated in the Company's 8K being filed with the U.S. Securities and Exchange Commission.
"Because Swiss Medica raised more than US$3.9 million in gross equity proceeds via the exercise of existing warrants in recent weeks, it was prudent to reduce our debt levels," said Chief Executive Officer, Raghu Kilambi. "We now have sufficient capital in place to move forward with our innovative advertising, sampling and public relations activities for the national U.S. launch of the O24 Essential Oil Pain Neutralizer, and to expand our marketing efforts in Canada."
About Swiss Medica Inc.
Swiss Medica commercializes proprietary bioscience products that relieve chronic ailments. We increase our market share through focused distribution strategies in multiple sales channels. Swiss Medica's mission is to be a world leader in the commercialization of life enhancing bioscience products that improve quality of lives. Please visit our websites at www.swissmedica.com and www.O24zone.com
Swiss Medica's flagship product, the O24(TM) Essential Oil Pain Neutralizer, holds US Patent #6,444,238B1. The O24(TM) pain relief solution has been used, recommended and praised for its fast-acting and long-lasting benefits by healthcare professionals in the United States, Canada and in Europe. O24(TM) is widely available throughout Canada in leading pharmacies and natural food stores. It is currently available in Happy Harry's Discount Drugstores in the United States, or by visiting www.O24zone.com, for ordering details and store locators.
Forward-looking statements in this news release are made pursuant to the "Safe Harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, risks relating to the ability to close transactions being contemplated, risks related to international sales and potential foreign currency exchange fluctuations, continued acceptance of Swiss Medica's products, increased levels of competition, technological changes, dependence on intellectual property rights and other risks detailed from time to time in Swiss Medica's periodic reports filed with the United States Securities and Exchange Commission and other regulatory authorities.
Swiss Medica Inc. David Jones Investor Relations Contact 1 866 485 4243 or Blue Skye PR, Inc. Sky Wallen Press Contact 813 732 6869 blueskyeinc@yahoo.com www.blueskyeinc.com
NEWS RELEASE TRANSMITTED BY CCNMatthews
Copyright (C) 2005, CCNMatthews. All rights reserved
Posts: 2 | Registered: Jan 2005
| IP: Logged |
posted
Swiss Medica Continues Aggressive Marketing and Sampling Programs for O24 Pain Neutralizer
By BusinessWire Last Update: 11/14/2005 9:02:01 AM Data provided by
TORONTO, Nov 14, 2005 (BUSINESS WIRE) -- Swiss Medica, Inc. (SWME) today announced that it has launched marketing programs with nationally syndicated radio programs to offer free samples of Swiss Medica's flagship brand O24 Pain Neutralizer to their national U.S. audiences.
Swiss Medica has recently launched a series of personally endorsed radio commercials with Dr. Laura Schlessinger ("Dr. Laura"). The syndicated Dr. Laura radio show is broadcast daily on 200 affiliate radio stations across the U.S. representing an 82% market penetration. Dr. Laura is the number one daily talk show in North America targeted at adult women and has an estimated weekly listening audience of 7.75 million. Dr. Laura is a user of O24 Pain Neutralizer and will talk about O24 daily during the course of her radio show.
Swiss Medica has also launched an extensive campaign for O24 Pain Neutralizer on U.S. nationally syndicated Fox Radio Sports. This campaign features personal endorsements by Fox personalities David Stein (morning show host), JT the Brick (late afternoon host) and Craig Shemon and James Washington (Game Time Live hosts). In each case, these personalities are using O24 Pain Neutralizer and benefiting from this safe and effective pain reliever. For examples of the Fox Radio Sports spots, please visit www.024zone.com/foxclips
In Canada, Swiss Medica has continued innovative media and sampling programs including the recently launched National Hockey League ("NHL") O24Zone Injury Report which appears on radio broadcasts for all 6 Canadian NHL professional hockey teams. This exclusive program also includes O24 Pain Neutralizer sampling to all guests on the radio broadcasts.
These media programs are an extension of the aggressive sampling and media program that Swiss Medica has been executing since the pharmacy launch of O24 Pain Neutralizer in fall of 2004. By the end of 2005, Swiss Medica will have distributed over 500,000 samples of O24 Pain Neutralizer to North American adults in medical and doctors offices, in pharmacies and other retailers, via media opportunities and at trade and consumer shows.
O24 Pain Neutralizer is available in the pain relief section of more that 19,000 North American retail outlets including the top 3 national drug chains in the USA. Please visit www.O24zone.com, for store locators.
About Swiss Medica, Inc.
Swiss Medica commercializes proprietary bioscience products that relieve chronic ailments. We increase our market share through focused distribution strategies in multiple sales channels. Swiss Medica's mission is to be a world leader in the commercialization of life enhancing bioscience products that improve quality of lives. Please visit our websites at www.swissmedica.com ,www.O24zone.com and www.pmsescape.com.
Swiss Medica's flagship product, the O24 Essential Oil Pain Neutralizer, holds US Patent #6,444,238B1. The O24 pain relief solution has been used, recommended and praised for its fast-acting and long-lasting benefits by healthcare professionals and athletes in the United States, Canada and in Europe. O24 is widely available throughout the United States and Canada in leading pharmacies and other retailers. Customers can also visit www.O24zone.com, for ordering details and store locators for the nearest pharmacy.
Swiss Medica has recently launching the patented O24 Fibromyalgia pain reliever (US Patent #6,444,238B1) over-the-counter in North American retailers. The National Fibromyalgia Association (NFA) recently awarded O24 Fibromyalgia their first NFA Seal of Approval. Upwards of 11 million Americans suffer from the long-term pain associated with Fibromyalgia. In a randomized double blind clinical trial, more than 90 per cent of the patients who used O24 Fibromyalgia reported mild to markedly better improvement, versus only 7 per cent who used the placebo. Customers can also visit www.O24zone.com, for ordering details and store locators for the nearest retailer.
Swiss Medica also manufactures PMS Escape(R) which holds US Patent #'s 5760014 and 5612320. PMS Escape(R) is a specially formulated group of carbohydrates, vitamins and minerals, clinically proven to reduce changes in mood and appetite that women experience during the premenstrual period. Customers can also visit: www.pmsescape.com for additional information and ordering details.
Forward-looking statements in this news release are made pursuant to the "Safe Harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, risks relating to the ability to close transactions being contemplated, risks related to international sales and purchases and potential foreign currency exchange fluctuations, continued acceptance of Swiss Medica's products, increased levels of competition, technological changes, dependence on intellectual property rights and other risks detailed from time to time in Swiss Medica's periodic reports filed with the United States Securities and Exchange Commission and other regulatory authorities.
Swiss Medica, Inc. (SWME)
SOURCE: Swiss Medica, Inc.
Posts: 21 | From: Rockville, MD | Registered: Aug 2005
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
